• Je něco špatně v tomto záznamu ?

Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice

J. Frýdlová, Z. Rychtarčíková, I. Gurieva, M. Vokurka, J. Truksa, J. Krijt,

. 2017 ; 12 (10) : e0186844. [pub] 20171026

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016258

Tmprss6-mutated mask mice display iron deficiency anemia and high expression of hepcidin. The aim of the study was to determine the effect of erythropoietin administration on proteins participating in the control of iron homeostasis in the liver and spleen in C57BL/6 and mask mice. Administration of erythropoietin for four days at 50 IU/mouse/day increased hemoglobin and hematocrit in C57BL/6 mice, no such increase was seen in mask mice. Erythropoietin administration decreased hepcidin expression in C57BL/6 mice, but not in mask mice. Erythropoietin treatment significantly increased the spleen size in both C57BL/6 and mask mice. Furthermore, erythropoietin administration increased splenic Fam132b, Fam132a and Tfr2 mRNA content. At the protein level, erythropoietin increased the amount of splenic erythroferrone and transferrin receptor 2 both in C57BL/6 and mask mice. Splenic ferroportin content was decreased in erythropoietin-treated mask mice in comparison with erythropoietin-treated C57BL/6 mice. In mask mice, the amount of liver hemojuvelin was decreased in comparison with C57BL/6 mice. The pattern of hemojuvelin cleavage was different between C57BL/6 and mask mice: In both groups, a main hemojuvelin band was detected at approximately 52 kDa; in C57BL/6 mice, a minor cleaved band was seen at 47 kDa. In mask mice, the 47 kDa band was absent, but additional minor bands were detected at approximately 45 kDa and 48 kDa. The results provide support for the interaction between TMPRSS6 and hemojuvelin in vivo; they also suggest that hemojuvelin could be cleaved by another as yet unknown protease in the absence of functional TMPRSS6. The lack of effect of erythropoietin on hepcidin expression in mask mice can not be explained by changes in erythroferrone synthesis, as splenic erythroferrone content increased after erythropoietin administration in both C57BL/6 and mask mice.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016258
003      
CZ-PrNML
005      
20180515103956.0
007      
ta
008      
180515s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0186844 $2 doi
035    __
$a (PubMed)29073189
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Frýdlová, Jana $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice / $c J. Frýdlová, Z. Rychtarčíková, I. Gurieva, M. Vokurka, J. Truksa, J. Krijt,
520    9_
$a Tmprss6-mutated mask mice display iron deficiency anemia and high expression of hepcidin. The aim of the study was to determine the effect of erythropoietin administration on proteins participating in the control of iron homeostasis in the liver and spleen in C57BL/6 and mask mice. Administration of erythropoietin for four days at 50 IU/mouse/day increased hemoglobin and hematocrit in C57BL/6 mice, no such increase was seen in mask mice. Erythropoietin administration decreased hepcidin expression in C57BL/6 mice, but not in mask mice. Erythropoietin treatment significantly increased the spleen size in both C57BL/6 and mask mice. Furthermore, erythropoietin administration increased splenic Fam132b, Fam132a and Tfr2 mRNA content. At the protein level, erythropoietin increased the amount of splenic erythroferrone and transferrin receptor 2 both in C57BL/6 and mask mice. Splenic ferroportin content was decreased in erythropoietin-treated mask mice in comparison with erythropoietin-treated C57BL/6 mice. In mask mice, the amount of liver hemojuvelin was decreased in comparison with C57BL/6 mice. The pattern of hemojuvelin cleavage was different between C57BL/6 and mask mice: In both groups, a main hemojuvelin band was detected at approximately 52 kDa; in C57BL/6 mice, a minor cleaved band was seen at 47 kDa. In mask mice, the 47 kDa band was absent, but additional minor bands were detected at approximately 45 kDa and 48 kDa. The results provide support for the interaction between TMPRSS6 and hemojuvelin in vivo; they also suggest that hemojuvelin could be cleaved by another as yet unknown protease in the absence of functional TMPRSS6. The lack of effect of erythropoietin on hepcidin expression in mask mice can not be explained by changes in erythroferrone synthesis, as splenic erythroferrone content increased after erythropoietin administration in both C57BL/6 and mask mice.
650    _2
$a zvířata $7 D000818
650    _2
$a cytokiny $x genetika $x metabolismus $7 D016207
650    _2
$a erythropoetin $x genetika $x farmakologie $7 D004921
650    _2
$a regulace genové exprese $x účinky léků $x genetika $7 D005786
650    _2
$a hepcidiny $x genetika $x metabolismus $7 D064451
650    _2
$a železo $x metabolismus $7 D007501
650    _2
$a játra $x metabolismus $x patologie $7 D008099
650    _2
$a membránové proteiny $x genetika $x metabolismus $7 D008565
650    _2
$a myši $7 D051379
650    _2
$a mutantní kmeny myší $7 D008817
650    _2
$a svalové proteiny $x genetika $x metabolismus $7 D009124
650    _2
$a velikost orgánu $x účinky léků $x genetika $7 D009929
650    _2
$a proteiny vázající RNA $x genetika $x metabolismus $7 D016601
650    _2
$a serinové endopeptidasy $x genetika $x metabolismus $7 D012697
650    _2
$a slezina $x metabolismus $x patologie $7 D013154
655    _2
$a časopisecké články $7 D016428
700    1_
$a Rychtarčíková, Zuzana $u Laboratory of Tumour Resistance, Institute of Biotechnology, BIOCEV Research Center, Czech Academy of Sciences, Vestec, Czech Republic. Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
700    1_
$a Gurieva, Iuliia $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Vokurka, Martin $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Truksa, Jaroslav $u Laboratory of Tumour Resistance, Institute of Biotechnology, BIOCEV Research Center, Czech Academy of Sciences, Vestec, Czech Republic.
700    1_
$a Krijt, Jan $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 12, č. 10 (2017), s. e0186844
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29073189 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515104129 $b ABA008
999    __
$a ok $b bmc $g 1299882 $s 1013098
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 12 $c 10 $d e0186844 $e 20171026 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Možnosti archivace